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Objective: Identify predictor variables and models for clini-
cal outcomes for primary care shoulder pain patients to 12 
months follow-up.
Design: A non-randomized audit with measures of pain and 
disability at 3 weeks, 3, 6 and 12 months. 
Patients: Of 208 patients, 161 agreed to participate with 
96.9, 98.1, 87.0 and 83.9% follow-up at 3 weeks, 3, 6 and 
12 months respectively. Treatment consisted of exercise and 
manual therapy-based physiotherapy and corticosteroid in-
jection under specified selection criteria.
Methods: Potentially useful baseline variables were evalu-
ated in univariate logistic regressions with the dependent 
variables determined by SPADI Questionnaire at 3 weeks, 
3, 6 and 12 months. Variables associated (p-value ≤ 0.2) were 
retained for potential inclusion within multiple logistic re-
gression analyses. 
Results: Pain not improved by rest, intermittent pain, lower 
pain intensity with physical tests and absence of subacro-
mial bursa pathology on ultrasound at the 3-week follow-
up, constant pain and lower pain intensity with physical 
tests are predictors of excellent outcomes at the 3-month 
follow-up. Worse baseline pain and disability, no history of 
asthma, pain better with rest, better physical functioning, 
greater fear avoidance, male gender, no history of pain in 
the opposite shoulder, pain referred below the elbow, sleep 
disturbed by pain, smaller waist circumference, lower pain 
intensity with physical tests are factors predictive of excel-
lent outcomes at the 12-month follow-up. Only higher pain 
intensity with physical tests was associated with a poor clini-
cal outcome.
Conclusion: Predictive models for clinical outcomes in pri-
mary-care patients with shoulder pain were achieved for 
excellent clinical outcomes, successfully classifying 70–90% 
of cases.
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J Rehabil Med 2015; 47: 66–71
Guarantor’s address: Dr Mark Laslett, 7 Baltimore Green, 
Shirley, Christchurch, 8061, New Zealand. E-mail: mark.
laslett@xtra.co.nz
Accepted May 26, 2014; Epub ahead of print Sep 3, 2014
IntRoductIon
Shoulder pain is one of the most common musculoskeletal 
complaints presenting to primary care practitioners with the 
average medical practice serving 2,500 registrants reported to 
conduct a mean of 148 consultations per year for new episodes 
of shoulder pain (1, 2). Shoulder pain does not spontaneously 
resolve in a significant proportion of cases naturally (2, 3) or 
following different treatment methods (4–8) with approxi-
mately half of patients consulting more than once for the same 
episode of shoulder pain (9). Prognosis therefore is mixed 
depending on factors such as pathology, personal character-
istics and specific circumstances of the individual patient and 
complaint of shoulder pain. the ability to identify prognostic 
indicators of a good or bad outcome following an episode of 
shoulder pain may enhance management of these patients. 
In a large prospective study on prognostic indicators of out-
come for shoulder pain patients in primary care, demographic, 
pain episode characteristics, patient physical characteristics, 
physical examination and psychosocial factors were prospec-
tively assessed to determine what factors or combinations of 
factors predicted poor outcomes at 6 weeks, 3 and 6 months after 
presentation (10). In that study, longer duration of symptoms at 
baseline, gradual onset of shoulder pain and higher pain inten-
sity were associated with a poorer prognosis at both 6 weeks and 
6 months. concomitant psychological complaints, performance 
of repetitive movements and higher neck pain scores at physi-
cal examination were associated with persistent symptoms at 6 
weeks. A poor prognosis at 6 months was additionally predicted 
by concomitant back pain and higher shoulder pain scores at 
physical examination. the physical examination of patients 
was limited to simple measures of shoulder and neck range of 
movement and pain with movement. All patients were managed 
by general medical practitioners (GPs) according to the 1999 
dutch shoulder pain management guidelines (11, 12) which 
consisted of information on the prognosis of shoulder pain, 
advice regarding provoking activities and stepwise treatment 
consisting of paracetamol, non-steroidal anti-inflammatory 
drugs, corticosteroid injection or referral for physiotherapy. the 
GP determined the content of treatment, based on duration and 
severity of pain and disability. the current study offered the 
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opportunity to evaluate a different suite of outcome measures 
and the value of a much more extensive and standardized clini-
cal examination that has been previously described in detail 
(13–17) over a longer follow-up period.
Part 1 of this report (18) presented an overview and results 
from a follow-up study of first contact primary care patients 
presenting to community physiotherapy and medical practices 
(13). Part 2 of this report focuses on in-depth analyses of po-
tential predictors of outcome from baseline examination data 
derived from the Part 1 analysis plus variables identified by 
previous research for which analogues were available from the 
current dataset. the purpose of this report is to identify baseline 
variables associated with clinical outcomes at 3 weeks, 3, 6 and 
12 months follow-up after initial presentation, and formulate 
potentially useful clinical prediction models. Identification of 
viable predictive models would assist the primary care clini-
cian in utilizing management protocols similar to the model 
used in this study where an excellent outcome is expected. 
Also early referral for high-tech imaging and surgical review 
would be appropriate if the components of a predictive model 
suggesting a poor clinical outcome is likely.
MEthodS
All patients inducted into a study of diagnostic accuracy among pri-
mary care shoulder pain patients (13) were invited to participate in a 
12-month follow-up study. outcomes were assessed at 3 weeks, 3, 6 
and 12 months following completion of a comprehensive diagnostic 
workup. In Part 1, variables significantly associated with higher scores 
on the Shoulder Pain and disability Index (SPAdI) (19) questionnaire 
as completed by 84% of participants at the 12-month follow-up, were 
identified and evaluated for possible inclusion into multiple regression 
models. Other variables have been identified by previous authors as 
having an association with outcome at 6 months and 12 months, and 
where our data provided information on a similar dimension or con-
struct, these were included in the initial list of variables for potential 
use in creating predictive models. 
Outcome measures:
1. SPADI questionnaire: the SPAdI questionnaire consists of 13 ques-
tions relating to pain and function with each question being scored 
in the range from 0 to 10 in single integer increments. there are two 
sections, with 5 questions relating to pain and 8 relating to function 
and disability. A zero score refers to no pain or disability and a 10 
score refers to maximum pain and disability. the maximum score 
therefore is 130 representing maximum pain and disability. the 
scores acquired were converted to a percentage by the calculation 
(total SPAdI score /130) × 100. the minimally clinically important 
difference (McId) for the primary outcome measure, the SPAdI 
total (%) score, was set at ± 13 percentage points (20).
2. categories of outcome were created by comparing baseline SPAdI 
total percentage scores with those at each follow-up assessment. using 
the McId, categories of change were created in order to estimate the 
proportions of cases recovering, staying the same or worsening over 
time: Excellent outcome: Score reduced to zero between assessment 
points or improvement was 90% or more from baseline; Better: Per-
centage reduction in score larger than the McId but less than 90%; 
Poor Outcome: change (increase or decrease) in score was less than 
the McId or increase in score was more than the McId (table I).
Statistical methods
Variables for inclusion in the initial evaluation for possible inclusion 
into predictive models were identified in two ways:
1. those variables associated with SPAdI total score at 12 months 
(p ≥ 0.2) from Part 1(18) of this report were included.
2. All other variables in our dataset that measured a similar concep-
tual construct as variables identified in previous research (3,10) as 
predictive of outcome at any time point.
All potential predictor variables were evaluated separately in uni-
variate logistic regressions with the dependent variable being clinical 
outcomes: “Excellent”, “Better” and “Poor” based on the SPAdI total 
at follow-up. Variables associated with the dependent variable (p-value 
≤ 0.2) were initially retained for inclusion within multiple backwards 
logistic regression analyses. Models were considered statistically sig-
nificant where p-value < 0.05. Where insufficient cases were available 
to construct models, the result was recorded as “not applicable” (n/A).
RESultS
Demographic and clinical history details, and flow of patients 
through the study for the sample, respectively, have been pre-
viously reported (13). of more than 160 variables considered 
as potential predictors of outcome, there were 26 having suf-
ficient cases for analyses and had associations strong enough in 
univariate regression analyses for at least one of the outcomes 
at least one of the follow-up periods, and were retained for 
inclusion in multiple regression models (table II). these vari-
ables were used to derive separate models for outcomes at the 
3-week, 3-month, 6-month and 12-month follow-up periods. 
due to the low number of cases with poor outcomes surviv-
ing the multiple regression modelling, there were only two vari-
ables that emerged in a final model for the short term 3-month 
follow-up: Medium or large rotator cuff tears as identified by 
ultrasound imaging (oR 5.65, 95% cI 0.97–32.72, p = 0.05), 
and higher reported pain intensity with index physical tests 
carried out at the 3-week follow-up assessment (oR 5.65, 95% 
cI 0.0–1.05, p = 0.07). the analysis therefore was reduced to a 
dichotomous outcome: an excellent outcome versus all other 
outcomes. the results of the analyses for excellent outcomes 
for the short and medium term follow-ups are presented. “Bet-
ter” or “Poor” outcomes are combined and produce the same 
but inverse results for an “excellent” outcome.
table I. Categorization of clinical outcomes 
change in SPAdI total % between assessments
+100% to –13% –14% to –89% –90% to –100%
“Poor” clinical outcome
SPAdI increased, same or increased by< McId
“Better” clinical outcome 
SPAdI decreased by > McId but < 90%
“Excellent” clinical outcome
SPAdI decreased 90–100%
SPAdI: Shoulder Pain and disability Index questionnaire; McId: Minimal clinically Important difference (13 percentage points). Zero represents 
the ‘best’ score (no pain or disability) on the SPAdI, and 100% represents the ‘worst’ score (maximum pain and disability). 
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Predictors of an excellent outcome at short term (3 weeks and 
3 months) follow-ups (Table III)
With an excellent clinical outcome as dependent variable, 
higher baseline SPAdI pain sub-score, pain not eased or best at 
rest, pain reported as intermittent (versus constant), lower Sf-8 
Mental component score (21), smaller waist circumference, 
lower pain intensity with index tests at 3-week follow-up, and 
the absence of Subacromial Bursa (SAB) pathology seen on 
ultrasound, were retained in the final equation for the 3-week 
follow-up, with 82% of the cases being correctly classified. 
Intermittent pain, patient report of not being woken by pain 
and lower pain intensity with index tests at 3-week follow-up 
were retained in the final equation for the 3-month follow-up, 
with 72% of the cases being correctly classified. 
Predictors of an excellent outcome at medium term (6 and 12 
months) follow-up (Table IV)
constant pain, higher baseline Sf-8 Physical functioning 
sub-score, higher baseline fABQ General sub-score (22) and 
evidence of acromioclavicular joint (AcJ) arthropathy on X-
ray were retained in the final equation for the 6 month follow-
up, with 67.5% of the cases being correctly classified. For the 
12 month follow-up, higher baseline SPAdI Pain sub-score, 
no history of asthma, pain eased or best when at rest, higher 
baseline Sf-8 Physical functioning sub-score and Physical 
component scores, higher baseline fABQ General sub-score, 
male gender, no history of pain in the opposite shoulder, refer-
ral of pain below the elbow, patient report of pain disturbing 
sleep, smaller waist circumference, lower pain intensity with 
index tests at the 3-week follow-up, a clinical diagnosis of 
adhesive capsulitis at baseline, were retained in the final model 
with 81.7% of the cases being correctly classified. 
dIScuSSIon
the emergent predictive models offer insights into factors 
that may help primary care clinicians in management. Male 
gender, smaller waist circumference, pain referred below the 
elbow, pain eased or better at rest, disturbed sleep, lower pain 
responses at physical examination, and higher physical func-
tion scores at baseline suggest a better outcome at 12 months. 
the opposite pattern would suggest poorer prognosis.
the strongest predictors of an excellent outcome at 12 
months were “pain eased or best at rest” (oR 10, 95% cI 2–48) 
and pain referred below the elbow (oR 27, 95% cI 3–225), 
both of which suggest that though pain may be more severe at 
baseline, there is a good probability of an excellent outcome 
over the medium or long term. these data may provide valuable 
reassurance to patients in whom high pain severity at baseline 
may be distressing, and potentially provide a prognostic indi-
cation of the slow time-frame for recovery for some patients.
Some factors like disturbed sleep and pain referred below 
the elbow seem counter-intuitively associated with an excel-
lent outcome, but may represent a proportion of cases with 
conditions like adhesive capsulitis that generally have a good 
natural history over 12 months and a good response to corti-
costeroid injection, yet typically report pain behaviours that 
are disruptive at initial assessment.
table II. Variables retained for multiple regression modelling
SPAdI total Score (%) at baseline
SPAdI Pain Score (%) at baseline
Gender
history of asthma
Past history shoulder pain in the opposite shoulder
Pain aggravated when reaching across the body
Pain is eased or at best when at rest
Ability to sleep on affected side
Pain disturbs sleep
Pain described as constant (24/7)
Pain is referred below the elbow
Sf-8 Vitality at baseline
Sf-8 General health score at baseline
Sf-8 Physical functioning score at baseline
Sf-8 Physical component score at baseline
Sf-8 Mental component score at baseline
Baseline VAS (mm) lowest level of pain
Baseline VAS (mm) mean level of pain
Baseline VAS (mm) highest level of pain
fABQ General Sub-score (%) at baseline
frozen shoulder: clinical diagnosis
Pain intensity with index pain tests carried out at 3-week follow-up 
assessment
Waist circumference (cm)
Thickening, fluid or calcification of the SAB on ultrasound imaging
Moderate or major rotator cuff tears as identified on ultrasound imaging
AcJ arthropathy of any sort seen on X-ray
SPAdI: Shoulder pain and disability Index Questionnaire; Sf-8: 
Short form 8 question questionnaire; fABQ: fear Avoidance Beliefs 
Questionnaire; VAS: visual analogue scale; SAB: subacromial bursa; 
AcJ: acromioclavicular joint.
table III. Results of multiple logistic regression analyses for an excellent clinical outcome at short term (3 weeks and 3 months) clinical outcomes 
3 weeks 3 months
Variable oR (95% cI) p-value Variable oR (95% cI) p-value
SPAdI Pain sub-score at Baseline 1.04 (1.00–1.08) 0.03 Pain is constant 2.50 (0.89–6.00) 0.08
Best or eased when at rest 0.06 (0.01–0.32) 0.00 Patient report of night pain (disturbs sleep) 0.36 (0.14–0.94) 0.04
Pain is constant 0.14 (0.03–0.72) 0.02 Pain intensity of index pain test at 3 weeks 0.98 (0.97–0.00) 0.03
Sf8 Mental component Score Baseline 0.93 (0.85–1.01) 0.08    
Waist circumference (cm) 0.95 (0.90–1.00) 0.05    
Pain intensity of index pain test at 3 
weeks
0.93 (0.89–0.96) 0.00    
Any SAB pathology (ultrasound) 0.12 (0.02–0.74) 0.02    
SPADI: Shoulder Pain and Disability Index Questionnaire; 95% CI: 95% confidence interval; SF8: Short Form 8 question questionnaire; SAB: 
subacromial bursa. oR: odds ratio.
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Predictors of poor outcome
While the ability to predict a ‘poor’ clinical outcome is of 
considerable value to inform decision makers regarding early 
intervention including the use of additional investigations, 
pain relief interventions, specialist consultations, allied health 
involvement (e.g occupational therapy) and vocational ser-
vices, there were only a small number of cases in the ‘poor’ 
outcome category for the variables retained in the prediction 
models. This made it difficult to identify strong predictors of 
this outcome from our cohort. 
A history of previous problems in the opposite shoulder was 
negatively associated with an excellent outcome at 12 months 
and positively associated with a poor outcome, which may sug-
gest some individual susceptibility to shoulder pathologies such 
as rotator cuff disease (23). this susceptibility may be environ-
mental, occupational or genetic separately or in combination, 
but this study design cannot offer any insights in that regard.
Comparison with other studies
While this study is not the first to observe and analyse progress 
of primary care shoulder patients, there appears to be differ-
ences in the new Zealand population compared to European 
counterparts. the differences between the present analysis 
and the study by Kuijpers et al. (24, 25) are likely because of 
different durations between assessments, in baseline clinical as-
sessment and a different mix of treatment options. In addition, 
the small number of cases with a poor outcome at follow-ups 
that survived the multiple regression modelling in the current 
data made some direct comparisons impossible. 
Some of the differences between the the study by Kuipjers 
et al. and the current results relate to the predictive nature of 
psychosocial factors which we found to be only weakly as-
sociated to poor outcomes (18). However we did find that a 
higher baseline fABQ General sub-score was associated with 
excellent outcomes at 6- and 12-month follow-ups. 
In the current data 42, 21 and 37% could be classified as 
acute (up to 6 weeks), subacute (7–12 weeks) and chronic (13 
weeks or more), respectively, similar to the results by Kuijpers 
et al. however, duration of symptoms at baseline was not 
a significant determinant of outcome in our study. We also 
found male gender was associated with an excellent outcome 
at 12 months. Kuijpers et al. found that lower pain severity at 
baseline and initial physical examination were related to an 
excellent outcome at 3 months. We observed a similar construct 
except that higher SPAdI pain sub-scores were associated with 
excellent outcomes at 3 weeks. lower pain intensity reported 
with physical test procedures carried out at the 3-week follow-
up emerged in the final models for excellent clinical outcomes 
at 3 weeks, 3 months and 12 months, but not at the 6-month 
follow-up. Physical testing was only carried out at baseline, 
3-week and 12-month follow-up. the results suggest that the 
clinician may guage progress by recording pain intensity with 
testing of the most painful active movements, passive tests, 
isometric tests and special tests at each follow-up. If the early 
trend is for reducing pain with testing, a better prognosis seems 
likely, whereas if pain intensity remains high in the first 3 
months, a poorer outcome at 12 months seems likely.
Imaging findings
With respect to X-ray and ultrasound image findings, an 
absence of SAB pathology survived to the final model for an 
excellent outcome at 3 weeks, and an X-ray finding of ACJ 
pathology was retained in the final model for an excellent 
outcome at 6 months. MR arthrograms were acquired for 
the subset of patients (45%) reporting less than an 80% pain 
relief from guided diagnostic injections to the SAB and AcJ, 
and variables representing imaged pathology were included 
in the initial analyses. no MR arthrogram-related variables 
survived to the final models, but it is highly probable that the 
low frequencies of various disorders in an already diminished 
sample is responsible for this analytic outcome. further re-
search is required where all patients receive MR arthrography 
to determine relationships between MR imaged pathology and 
outcome in primary care populations. 
table IV. Results of multiple logistic regression analyses for an excellent clinical outcome at medium term (6 and 12 months) clinical outcomes
6 months 12 months
Variable odds ratio (95% cI) p-value Variable odds ratio (95% cI) p-value
Pain is constant 2.71 (0.92–8.05) 0.07 Baseline SPAdI Pain sub score 1.03 (1.00–1.07) 0.08
Baseline Sf8 Physical functioning Score 1.00 (1.02–1.18) 0.02 history of asthma 0.13 (0.02–0.96) 0.05
Baseline fABQ General Score (%) 1.03 (1.00–1.07) 0.08 Pain eased or best when at rest 10.01 (2.09–48.05) 0.00
Any AcJ pathology (X-ray) 3.67 (0.86–15.68) 0.08 Baseline Sf8 Physical functioning Score 1.14 (1.03–1.25) 0.01
   Baseline Sf8 Physical component Score 1.11 (1.01–1.22) 0.04
   Baseline fABQ General Score (%) 1.01 (1.03–1.17) 0.00
   Male gender 0.18 (0.04–0.90) 0.04
   history of pain in the opposite shoulder 0.07 (0.01–0.46) 0.01
   Pain referred below the elbow 26.78 (3.19–225.11) 0.00
   Patient report of night pain (disturbs sleep) 5.17 (0.91–29.39) 0.06
   Waist circumference (cm) 0.94 (0.90–0.99) 0.02
   Pain intensity of index pain test at 3 weeks 0.97 (0.95–0.1.00) 0.03
   diagnosis Adhesive capsulitis at baseline 23.19 (0.63–856.47) 0.09
SPADI: Shoulder pain and disability Index Questionnaire; 95% CI: 95% Confidence Interval; SF-8: Short Form 8 question questionnaire; FABQ: Fear 
Avoidance Beliefs Questionnaire; cm: centimetre; VAS: visual analogue scale; AcJ: acromioclavicular joint.
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New information
Other variables not previously identified emerged as predic-
tors of outcome, were no history of asthma and smaller waist 
circumference being associated with an excellent outcome at 
12 months. there is evidence that increased central adipos-
ity may have systemic effects on musculoskeletal pathology 
and degenerative conditions – more than could be expected 
consequent on increased load from increased bodyweight 
(26), and there is evidence that obesity is a risk factor in non-
weightbearing joints such as the carpometacarpal joints (27). 
the shoulder is not a weight bearing joint either, so it may 
be that increased waist circumference (central adiposity) is a 
risk factor for rotator cuff tendinopathy in the same way as it 
appears to be for patellar tendinopathy (28). 
the clinical diagnosis of adhesive capulitis produced an 
oR of 23 in relation to an excellent outcome at 12 months, 
but the wide 95% CI (0.63–856) reflects the small number of 
cases in the initial sample (n = 9). A different issue occurs in 
relation to the patient report of pain disturbing sleep at night 
where the oR is 5.1 (95% cI 0.91–29). the large 95% cI was 
due to a larger number of patients being misclassified by this 
particular logistic regression model as opposed to some of the 
models for other significant variables. 
Limitations of the study
this follow-up study was not a randomized controlled trial, 
and cause and effect relationships cannot be inferred from 
our results. however, these results provide valuable observa-
tions on the outcome of primary-care patients with shoulder 
pain providing clinicians with information regarding factors 
associated with poor and excellent outcomes and what may 
be expected throughout a 12-month period with steroid injec-
tion (using strict criteria), exercise and manual therapy-based 
physiotherapy management. Apart from specific criteria for the 
use of corticosteroid injection, other treatment throughout the 
period from the 3-week and 12-month follow-ups was not con-
trolled or accurately determined. the value of physiotherapy 
or influence of medication on outcomes could not be assessed. 
further study of these factors is warranted.
It is acknowledged that although the sample size is respect-
able, the large number of potential predictor variables col-
lected may limit the robustness of conclusions because of our 
selection criteria for inclusion in multiple regression models. 
the lack of data for some patients with poor outcomes at the 
different follow-up periods caused them to be rejected in the 
analysis, limiting ability to provide models for poor outcomes. 
the choice of 90% reduction of pain and disability as the 
cut-off point for an excellent clinical outcome is necessarily 
arbitrary and another value such as 75 or 50% could have been 
chosen. however, the authors considered that the primary 
objective of treatment is complete or near complete recovery, 
certainly by 12 months following presentation to primary 
care. from this perspective, anything other than complete or 
near-complete recovery can be considered as unsatisfactory.
Conclusion
this study identified variables associated with excellent 
clinical outcomes at 12 months after presentation to mostly 
physiotherapists at primary care level in new Zealand. the 
nature of care was not standardized except for a clear protocol 
for selection of cases for corticosteroid injection followed by 
firm post-injection instructions. Pain eased or best at rest and 
pain referred below the elbow were the strongest predictors 
of an excellent outcome in the medium term. only higher pain 
scores with physical testing at the 3-week follow-up emerged 
as a predictor of poor clinical outcome, and only at 3 months. 
duration of symptoms prior to presentation and psychosocial 
distress issues did not seem to influence outcomes meaning-
fully, but severity of pain at initial assessment is relevant. 
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